FLATT DEAN M
Known title: DirectorCIK: 0001474732
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 11, 2026
Guggenheim initiates coverage on DCO with $246 target. Guggenheim has initiated coverage on Ducommun, assigning a Buy rating and a price target of $246. This new analyst view places the target above the current average analyst estimate of $212. The stock is currently trading near its 52-week high, reflecting recent positive momentum.
Transaction History
| CW | ▲ Buy | Grant | 218 | $144K | 1/20/2026 | View on chart |
| CW | ▲ Buy | Grant | 727 | $416K | 1/2/2026 | View on chart |
| CW | ▲ Buy | Grant | 370 | $165K | 6/3/2025 | View on chart |
| CW | ▲ Buy | Grant | 725 | $255K | 1/2/2025 | View on chart |
| DCO | ▲ Buy | Grant | 2,400 | $0 | 5/14/2024 | View on chart |
| CW | ▲ Buy | Grant | 505 | $112K | 1/3/2024 | View on chart |
| DCO | ▲ Buy | Grant | 3,400 | $136K | 5/18/2023 | View on chart |
| DCO | ▲ Buy | Grant | 2,000 | $0 | 4/26/2023 | View on chart |
| CW | ▲ Buy | Grant | 276 | $46K | 1/11/2023 | View on chart |
| CW | ▲ Buy | Grant | 332 | $55K | 1/4/2023 | View on chart |
| DCO | ▲ Buy | Grant | 1,800 | $0 | 4/22/2022 | View on chart |
| CW | ▲ Buy | Grant | 275 | $38K | 1/12/2022 | View on chart |
| CW | ▲ Buy | Grant | 110 | $15K | 1/5/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Curtiss-Wright (CW) Eyes Earnings Beat, Adds Nuclear Simulator
Analysts are questioning whether Curtiss-Wright will again exceed earnings estimates in its upcoming report. The company also installed a Stage 1 simulator at TerraPower’s Natrium nuclear site in Kemmerer, Wyoming, highlighting its involvement in advanced reactor development. These developments keep the stock in focus as it trades near the lower end of its 52‑week range.
Curtiss-Wright (CW) Eyes Earnings Beat, Adds Nuclear Simulator. Analysts are questioning whether Curtiss-Wright will again exceed earnings estimates in its upcoming report. The company also installed a Stage 1 simulator at TerraPower’s Natrium nuclear site in Kemmerer, Wyoming, highlighting its involvement in advanced reactor development. These developments keep the stock in focus as it trades near the lower end of its 52‑week range.